Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Polish insulin maker Bioton said on Tuesday it had put on hold its acquisition of Ukrainian firm Indar, after it learnt the Ukrainian state had lost control over the stake it had sought.
Bioton said in a statement that the 70% stake owned by the state was transferred to Gerist Invest Limited, but Ukrainian authorities had taken action to retake control over the firm, which also makes insulin. “The company suspends actions aimed at taking control of Indar until the legal situation of Indar shares is resolved,” Bioton said. In February Bioton CEO Adam Wilczega told Reuters, the company wanted to double its stake at Indar to 60%. (Reuters)